Charleston, SC -- (SBWIRE) -- 08/29/2013 -- Today’s Penny Stocks wants you, the investor, to have the ability to be informed in your trading decisions. Our website is designed to take you to the information you need to be at the top of your game in trading penny stocks. Today’s Penny Stocks issues news updates on the following stock: Generex Biotechnology Corporation (OTCMKTS:GNBT), Avanir Pharmaceuticals Inc (NASDAQ:AVNR), Stereotaxis Inc (NASDAQ:STXS), Prana Biotechnology Limited (ADR) (NASDAQ:PRAN).
Generex Biotechnology Corporation (OTCMKTS:GNBT) reported a plunge of -3.51%, after opening at the price of $0.04. Its closing price for the day was $0.0330. GNBT’s total trading volume for the day was 2.58 million shares, versus its average volume of 2.91 million shares. Generex Biotechnology Corporation, a development stage company, engages in the research, development, and commercialization of drug delivery systems and technologies for metabolic and immunological diseases.
Has GNBT Found The Bottom and Ready To Move Up? Find Out Here
Avanir Pharmaceuticals Inc (NASDAQ:AVNR), reported to close at $5.16, with the total traded volume of 2,555,254 shares. The stock’s opening price was $4.93.The 52-week price range of the stock remained $2.07 - $5.40, while during last trade its minimum price was $4.88 and it gained its highest price of $5.28. Avanir Pharmaceuticals, Inc., together with its subsidiaries, engages in acquiring, developing, and commercializing novel therapeutic products for the treatment of central nervous system disorders primarily in the United States.
For How Long AVNR’s Gloss will Attract Investors? Find out via this report
Another stock moving downward during previous trade, Stereotaxis Inc (NASDAQ:STXS) ended its day with the loss of -3.04% and closed at the price of $3.83, after opening at $3.94. Stock traded during its last trading session with the total volume of 2,443,580 shares, as compared to its average volume of 3.56 million shares. Stereotaxis, Inc. designs, manufactures, and markets cardiology instrument control system in the United States and internationally. Its products include Niobe ES robotic magnetic navigation system that enables physicians to navigate catheters, guidewires, and other delivery devices through the blood vessels and heart chambers to treatment sites.
Why Should Investors Buy STXS After the Recent Fall? Just Go Here and Find Out
One more company, which took investors’ attention and was moving negative during the previous trading session, Prana Biotechnology Limited (ADR) (NASDAQ:PRAN) reported the decrease of -12.50%, to close at $4.90, with the overall traded volume of 2,423,649 shares. During last trade, the company’s minimum price was $4.83, while it touched its highest price of $5.59. Prana Biotechnology Limited engages in the research and development of therapeutic drugs for the treatment of neurological disorders in Australia. The company primarily focuses on the Alzheimers, Parkinsons, and Huntingtons diseases, as well as various cancer, age-related macular degeneration and cataract, Motor Neuron, and Creutzfeldt-Jakob diseases.
Will PRAN Get Buyers Even After The Recent Rally? Find Out Here
About Today’s Penny Stocks
Today’s Penny Stocks wants you, the investor, to have the ability to be informed in your trading decisions. Our website is designed to take you to the information you need to be at the top of your game in trading penny stocks. Today’s wants you to do your own due diligence on your investments please use our site to find the information you need on whichever investment you choose.
The disclaimer is to be read and fully understood before using our site, or joining our newsletter email list. Never invest into a stock discussed on this web site or the TodaysPennyStocks.com newsletter unless you can afford to lose your entire investment.
Please consult with a certified financial advisor before making any investment decisions.
TodaysPennyStocks.com is owned and operated by FlipVentures LLC. We are engaged in the business of advertising and promoting companies for monetary compensation. All content in our releases is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities.
Read Full Disclaimer at: http://todayspennystocks.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)